Alpine Global Management, LLC Terns Pharmaceuticals, Inc. Transaction History

Alpine Global Management, LLC

  • $331 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$4.54 - $8.2 $72,994 - $131,839
16,078 New
16,078 $109,000
Q2 2023

Aug 06, 2024
BUY
$7.35 - $13.29 $78,314 - $141,604
10,655 New
10,655 $93,000
Q2 2023

Nov 21, 2023
BUY
$7.35 - $13.29 $78,314 - $141,604
10,655 New
10,655 $93,000
Q2 2023

Aug 14, 2023
BUY
$7.35 - $13.29 $78,314 - $141,604
10,655 New
10,655 $93,000

Others Institutions Holding TERN

# of Institutions
167
Shares Held
78.3M
Call Options Held
580K
Put Options Held
454K
View Full List

About Terns Pharmaceuticals, Inc.

TERN Quotes by TradingView
  • Ticker TERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,613,800
  • Market Cap $232M
  • Description
  • Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...
More about TERN
Track This Portfolio

Track Alpine Global Management, LLC Portfolio

Follow Alpine Global Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Global Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email